These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16601371)

  • 21. Hemorrhagic pleural effusion as a complication of chronic lymphocytic leukemia.
    Zeidman A; Yarmolovsky A; Djaldetti M; Mittelman M
    Haematologia (Budap); 1995; 26(3):173-5. PubMed ID: 7797147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas.
    Moulin B; Ronco PM; Mougenot B; Francois A; Fillastre JP; Mignon F
    Kidney Int; 1992 Jul; 42(1):127-35. PubMed ID: 1635342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.
    Saxena A; Viswanathan S; Moshynska O; Tandon P; Sankaran K; Sheridan DP
    Am J Hematol; 2004 Jan; 75(1):22-33. PubMed ID: 14695629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic lymphatic leukemia. A population-based study of symptoms, findings, complications and choice of treatment].
    Ly B; Hammerstrøm J; Bergheim J; Dahl IM; Grøttum KA; Lødemel B
    Tidsskr Nor Laegeforen; 1998 Jan; 118(2):228-32. PubMed ID: 9485617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
    Robak T
    Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe tetraparesis as the first manifestation of a chronic lymphatic leukemia].
    Gunsilius E; Hülser PJ; Heimpel H; Kornhuber HH; Seifried E
    Dtsch Med Wochenschr; 1992 Sep; 117(36):1359-62. PubMed ID: 1516530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrotic syndrome associated with chronic lymphocytic leukemia: an immunological and pathological study.
    Touchard G; Preud'homme JL; Aucouturier P; Giraud C; Gouet D; Yver L; Patte D
    Clin Nephrol; 1989 Feb; 31(2):107-16. PubMed ID: 2465858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of chronic lymphocytic leukemia.
    Han T; Rai KR
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic rhinitis: a manifestation of chronic lymphocytic leukemia.
    Amir R; Dowdy YG; Goldberg AN
    Am J Otolaryngol; 1999; 20(5):328-31. PubMed ID: 10512144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
    Lindhagen E; Nissle S; Leoni L; Elliott G; Chao Q; Larsson R; Aleskog A
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):545-53. PubMed ID: 17186240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL.
    Klepfish A; Gilles L; Ioannis K; Rachmilewitz EA; Schattner A
    Ann N Y Acad Sci; 2009 Sep; 1173():865-73. PubMed ID: 19758239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro induction of apoptosis in chronic lymphoid leukemia B lymphocytes by theophylline: therapeutic applications].
    Binet JL; Mentz F; Baudet S; Ouaaz F; Merle-Béral H
    Bull Acad Natl Med; 1995 Oct; 179(7):1379-91; discussion 1391-2. PubMed ID: 8556412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible renal failure due to specific infiltration of the kidney in chronic lymphocytic leukaemia.
    Comerma-Coma MI; Sans-Boix A; Tuset-Andújar E; Andreu-Navarro J; Pérez-Ruiz A; Naval-Marcos I
    Nephrol Dial Transplant; 1998 Jun; 13(6):1550-2. PubMed ID: 9641192
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
    Robak T; Blonski JZ; Kasznicki M; Góra-Tybor J; Dmoszyñska A; Skotñicki A
    Haematologica; 2005 Jul; 90(7):994-6. PubMed ID: 15996945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryoglobulinemia in a patient with chronic lymphocytic leukemia - A case report and review of literature of renal involvement in CLL.
    Arora S; Levitan D; Regmi N; Sidhu G; Gupta R; Nicastri AD; Saggi SJ; Braverman A
    Blood Cells Mol Dis; 2016 Sep; 60():7-11. PubMed ID: 27519936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.